A combined immune and inflammatory indicator predict the prognosis of severe Pneumocystis jirovecii pneumonia patients: a 12-year, retrospective, observational cohort.

MLA

Wang, Dong, et al. “A Combined Immune and Inflammatory Indicator Predict the Prognosis of Severe Pneumocystis Jirovecii Pneumonia Patients: A 12-Year, Retrospective, Observational Cohort.” BMC Pulmonary Medicine, vol. 24, no. 1, June 2024, p. 285. EBSCOhost, https://doi.org/10.1186/s12890-024-03093-8.

APA

Wang, D., Guan, L., Li, X., & Tong, Z. (2024). A combined immune and inflammatory indicator predict the prognosis of severe Pneumocystis jirovecii pneumonia patients: a 12-year, retrospective, observational cohort. BMC Pulmonary Medicine, 24(1), 285. https://doi.org/10.1186/s12890-024-03093-8

Chicago

Wang, Dong, Lujia Guan, Xuyan Li, and Zhaohui Tong. 2024. “A Combined Immune and Inflammatory Indicator Predict the Prognosis of Severe Pneumocystis Jirovecii Pneumonia Patients: A 12-Year, Retrospective, Observational Cohort.” BMC Pulmonary Medicine 24 (1): 285. doi:10.1186/s12890-024-03093-8.